Short Interest in Omron Corp. (OTCMKTS:OMRNY) Grows By 56.0%

Omron Corp. (OTCMKTS:OMRNY) was the recipient of a significant increase in short interest during the month of January. As of January 30th, there was short interest totaling 16,138 shares, an increase of 56.0% from the January 15th total of 10,346 shares. Based on an average daily trading volume, of 64,084 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.0% of the company’s stock are short sold. Currently, 0.0% of the company’s stock are short sold. Based on an average daily trading volume, of 64,084 shares, the days-to-cover ratio is currently 0.3 days.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Omron stock. GAMMA Investing LLC boosted its position in Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,129 shares of the company’s stock after purchasing an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent SEC filing. 1.09% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Omron from a “strong sell” rating to a “hold” rating in a research note on Monday, January 19th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock presently has an average rating of “Hold”.

Omron Stock Up 0.1%

OMRNY opened at $31.20 on Friday. The company has a quick ratio of 1.40, a current ratio of 2.14 and a debt-to-equity ratio of 0.13. The firm has a 50 day moving average price of $26.19 and a 200-day moving average price of $26.56. Omron has a twelve month low of $23.23 and a twelve month high of $32.00. The stock has a market capitalization of $6.43 billion, a price-to-earnings ratio of 39.49, a PEG ratio of 0.62 and a beta of 0.98.

Omron (OTCMKTS:OMRNY) last issued its earnings results on Thursday, February 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.19). The company had revenue of $1.41 billion during the quarter, compared to analysts’ expectations of $1.38 billion. Omron had a return on equity of 2.46% and a net margin of 2.80%.Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Equities research analysts forecast that Omron will post 0.42 earnings per share for the current year.

About Omron

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.